BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26508185)

  • 1. Remission of autoimmune neutropenia after development of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Ichimura T; Kaneyasu H; Shimomura M; Wakabayashi-Takahara M; Nakamura K; Kobayashi M; Ohga S
    Pediatr Int; 2015 Oct; 57(5):1012-4. PubMed ID: 26508185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases.
    Bux J; Behrens G; Jaeger G; Welte K
    Blood; 1998 Jan; 91(1):181-6. PubMed ID: 9414283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm.
    Onouchi Z; Hamaoka K; Ozawa S; Sakata K; Kiyosawa N; Ito H
    Pediatr Int; 2009 Aug; 51(4):448-52. PubMed ID: 19674356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response to granulocyte colony-stimulating factor in an autoimmune neutropenic adult.
    Imoto S; Hashimoto M; Miyamoto M; Murayama T; Murayama M; Nakamura M; Matsui T; Chihara K; Ryo R
    Acta Haematol; 1999; 101(3):153-6. PubMed ID: 10352336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and secondary autoimmune neutropenia.
    Capsoni F; Sarzi-Puttini P; Zanella A
    Arthritis Res Ther; 2005; 7(5):208-14. PubMed ID: 16207350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Kawasaki syndrome in autoimmune neutropenia after treatment with granulocyte colony-stimulating factor.
    Ueno K; Nomura Y; Arata M; Maruyama S; Tanabe T; Eguchi T; Kawano Y
    Pediatr Int; 2011 Jun; 53(3):388-90. PubMed ID: 21696506
    [No Abstract]   [Full Text] [Related]  

  • 8. A Rare Case of Adult Autoimmune Neutropenia Successfully Treated with Prednisolone.
    Fujita M; Kawabata H; Oka T; Hishizawa M; Kitano T; Kondo T; Yamashita K; Yurugi K; Hirai H; Maekawa T; Takaori-Kondo A
    Intern Med; 2017; 56(11):1415-1419. PubMed ID: 28566608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki disease.
    Sundel RP
    Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immunoglobulins for neonatal alloimmune neutropenia refractory to recombinant human granulocyte colony-stimulating factor.
    Desenfants A; Jeziorski E; Plan O; Rodière M; Rimbert M; Muller JY; Taïb J; Cambonie G
    Am J Perinatol; 2011 Jun; 28(6):461-6. PubMed ID: 21136350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunct cyclosporine therapy for refractory Kawasaki disease in a very young infant.
    Okada S; Azuma Y; Suzuki Y; Yamada H; Wakabayashi-Takahara M; Korenaga Y; Akase H; Hasegawa S; Ohga S
    Pediatr Int; 2016 Apr; 58(4):295-8. PubMed ID: 26670024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic neutropenia - experience from the Department of Immunology, Children's Memorial Health Institute].
    Klaudel-Dreszler M; Pietrucha B; Skopczynska H; Pac M; Kurenko-Deptuch M; Heropolitanska-Pliszka E; Wolska-Kusnierz B; Maslanka K; Bernatowska E
    Med Wieku Rozwoj; 2007; 11(2 Pt 1):145-52. PubMed ID: 17625284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of peripheral blood toxic neutrophils as a predictor of coronary risk in Kawasaki disease--the pathogenetic role of hematopoietic colony-stimulating factors (GM-CSF, G-CSF).
    Takeshita S; Sekine I; Fujisawa T; Yoshioka S
    Acta Paediatr Jpn; 1990 Oct; 32(5):508-14. PubMed ID: 1704677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired chronic neutropenia.
    Invernizzi R
    Haematologica; 1994; 79(1):4-6. PubMed ID: 15378941
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential role of autoantibody in severe neutropenia of a patient with Kawasaki Syndrome.
    Ueno K; Nomura Y; Masamoto I; Masuda K; Morita Y; Eguchi T; Okamoto Y; Kawano Y
    Scand J Immunol; 2012 Jan; 75(1):120-6. PubMed ID: 21923741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary autoimmune neutropenia in adults: case report and review of the literature.
    Mariotti J; Caberlon S; Bertinato E; Podda G; Pugliano MT; Cattaneo M
    Transfusion; 2014 Nov; 54(11):2906-10. PubMed ID: 24827415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sustained complete remission for one year following low-dose rituximab therapy for chronic autoimmune neutropenia].
    Hagihara M; Hua J; Inoue M; Michikawa N; Taniguchi K; Kobayashi M
    Rinsho Ketsueki; 2011 Feb; 52(2):63-7. PubMed ID: 21403425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P; Ausili E; Schiavino A; Angelone DF; Focarelli B; De Rosa G; Ranno O
    Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reply to questions regarding diagnosis and treatment of Kawasaki disease].
    Wang HW
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):337-8. PubMed ID: 16780708
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD; Zhao D; DU JB; Lu S; Yi JM; Hou AC; Zhou ZS; Ding GF;
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3119-21. PubMed ID: 18269869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.